Muscle ultrasound in patients with late-onset Pompe disease identified by newborn screening
Importance: Implementation of newborn screening (NBS) in the United States now detects infants with late-onset Pompe disease (LOPD), a lysosomal storage disease characterized by slowly progressive muscle weakness, and detailed clinical evaluation has identified early muscle weakness. Biomarkers may...
Main Authors: | David G. Jackson, Laura E. Case, Erin Huggins, Maggie Holland, Janet Blount, Lisa Hobson Webb, Priya S. Kishnani |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-09-01
|
Series: | Molecular Genetics and Metabolism Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214426923000356 |
Similar Items
-
Quantitative muscle ultrasound and electrical impedance myography in late onset Pompe disease: A pilot study of reliability, longitudinal change and correlation with function
by: Lisa D. Hobson-Webb, et al.
Published: (2021-09-01) -
The First Year Experience of Newborn Screening for Pompe Disease in California
by: Hao Tang, et al.
Published: (2020-02-01) -
Newborn Screening for Pompe Disease: Pennsylvania Experience
by: Can Ficicioglu, et al.
Published: (2020-11-01) -
A Qualitative Study: Mothers’ Experiences of Their Child’s Late-Onset Pompe Disease Diagnosis Following Newborn Screening
by: Kaylee Crossen, et al.
Published: (2022-07-01) -
Establishing Pompe Disease Newborn Screening: The Role of Industry
by: Joan M. Keutzer
Published: (2020-07-01)